Shoulder & Elbow · 2020 · 12 citations · 27 references
MedicineOrthopaedic SurgerySurgeryCost-effectiveness AnalysisOrthopedicsShoulder SurgeryCost-effectiveness ComparisonHealthcare Cost AnalysisIncremental Cost-effectiveness AnalysisResource Utilization MeasurementRevision Shoulder SurgeryShoulder ArthroplastyCost-effectivenessEuroqol Five DimensionsHealth Care EconomicsPatient Outcomes MeasurementReverse Total Shoulder ArthroplastyRevision Reverse Shoulder ArthroplastyRotator Cuff Tear ArthropathySurgical Cost-effectiveness Analysis
BACKGROUND: The primary aim of this study was to determine the cost-effectiveness of the reverse total shoulder arthroplasty in a prospective cohort of patients over a two-year post-operative period. METHODS: Patients who underwent reverse total shoulder arthroplasty were prospectively monitored for 24 months post-operatively using the Oxford Shoulder Score, Disabilities of the Arm, Shoulder and Hand questionnaire and EuroQol 5-dimensional questionnaire. Any complications or use of health care resources were recorded. The incremental cost-effectiveness ratio was used to express the cost per quality-adjusted life year gained. RESULTS: Sixty-seven patients were analysed, 46 primary reverse total shoulder arthroplasty for cuff arthropathy and 21 revisions from previous arthroplasty. Both indications had comparable peri-operative shoulder scores without significant difference. Using the mean change of EuroQol 5-dimensional questionnaire at one year, the incremental cost-effectiveness ratio was calculated at £16,827.43 per quality-adjusted life year, decreasing to £8313.48 per quality-adjusted life year at two years. Primary was associated with a lower incremental cost-effectiveness ratio at two years (primary £7596.76 vs. revision £11,748.51). The estimated post-operative life expectancy of the cohort was 6.9 years with a projected cost per quality-adjusted life year of £2438.78. CONCLUSIONS: Reverse total shoulder arthroplasty provides a cost-effective intervention with excellent patient outcomes at two years post-operatively.
27
Recommendations of the Panel on Cost-Effectiveness in Health and Medicine
Milton C. Weinstein · JAMA · 1996 · 2.5K citations
Pascal Boileau, Duncan Watkinson, Armodios M. Hatzidakis et al. · Journal of Shoulder and Elbow Surgery · 2006 · 1.1K citations
Glenoid loosening in total shoulder arthroplasty
Jonathan L. Franklin, William P. Barrett, Sarah E. Jackins et al. · The Journal of Arthroplasty · 1988 · 686 citations